Intertek Cantox Assists Companies with Addressing
Nanomaterial Safety Concerns
[Ontario, Canada] - Intertek Cantox, a leading provider of
scientific and regulatory consulting services to the food,
chemical, and pharmaceutical industries, announces the
development of a method to promote high quality
nanotoxicology studies allowing companies to ensure the
safety of nanotechnology and nanomaterials based products
entering the market.
With increasing interest in the use of nano-materials in a
wide variety of industries, the number of published studies
on the safety of nanomaterials continues to grow. During the
Materials Research Society meeting held in November 2011, Dr.
Jeffrey Card, Senior Program Manager in Toxicology at
Intertek presented on the evaluation of the published
literature on the safety of oral exposure to
nanomaterials.
Dr. Card and his colleagues developed and tested a two-step
Nano Study Score method to assess the overall quality of
studies that examine the toxicity of nanomaterials. A
comprehensive literature search identified 30 publications in
which a toxicological endpoint was assessed following in vivo
(oral) or in vitro exposure to food-related nanomaterials.
Overall, using the Nano Study Score method, the evaluation
indicated that there are currently insufficient reliable data
to allow clear assessment of the safety of oral exposure to
food-related nanomaterials. Significant investment must be
made to generate studies of sufficient quality and duration,
and that report comprehensive nanomaterial characterization
such that results can be judged reliable and interpretable.
Moreover, it is anticipated that the use and evolution of the
Nano Study Score method will assist with the design,
reporting, review, and interpretation of studies evaluating
the potential toxicity of nanomaterials administered by
various routes.
"Nanotechnology is having an impact in nearly every business
area. There often is a lack of knowledge regarding what
characteristics of a given nanomaterial may be responsible
for its adverse effects in a particular study simply because
adequate physicochemical characterization was not conducted
or reported.", says Dr. Card. "We want to close that gap so
that we may gain a better understanding of the properties of
nanomaterials that underlie their toxicity. Doing so will
assist businesses with achieving the ultimate goal of
developing safe nanotechnology-based products."
Dr. Card's presentation on assessing the quality of
nanotoxicology studies was highlighted in Nature and can be
located here as it focuses on regulatory guidance for
nanomaterials (). To learn more about nanotechnology
capabilities and services at Intertek, please visit .
For Market Inquiries:
About Intertek Cantox
Intertek Cantox is part of Intertek Health, Environmental and
Regulatory Services () offering an expansive range of
specialized expertise in the areas of Food & Nutrition,
Pharmaceutical & Healthcare, Chemicals, and Agriculture,
Biotech & Consumer Products. For over 25 years, the
specialists at Intertek Cantox have been helping companies
resolve complex scientific and toxicology issues, develop
scientific and strategic regulatory compliance plans, and
facilitate timely regulatory global approvals. Intertek
Cantox professionals deliver success and minimize client risk
through the company's broad expertise and knowledge of the
regulatory approval processes that govern food, drug,
cosmetic, consumer, commercial and industrial products in
North America, Europe, and other jurisdictions around the
world. For more information, visit .
About Intertek
Intertek is a leading provider of quality and safety
solutions serving a wide range of industries around the
world. From auditing and inspection, to testing, quality
assurance and certification, Intertek people are dedicated to
adding value to customers' products and processes,
supporting their success in the global marketplace. Intertek
has the expertise, resources and global reach to support its
customers through its network of more than 1,000 laboratories
and offices and 30,000 people in over 100 countries around
the world. Intertek Group plc (LSE: ITRK) is listed on the
London Stock Exchange and is a constituent of the FTSE 100
index.
distribué par | Ce noodl a été diffusé par Intertek Group plc et initialement mise en ligne sur le site http://www.intertek.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-05 17:41:35 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |